76Bio, Inc. — Form D/A
76Bio, Inc. of Boston, MA, a company, filed a Form D amendment with the SEC on 2023-02-14. The offering totals $12.2M, of which $12.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-02-14
- Form: D/A
- Accession: 0001437749-23-003303
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $12.2M
- Amount sold: $12.2M
- Investors: 32
- Date of first sale: 2023-02-06
- Revenue range: Decline to Disclose
- SEC file number: 021-473359
Issuer
- Name: 76Bio, Inc.
- CIK: 0001903465
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 40 Guest Street, Boston, MA, 01235
- Phone: 212-871-7920
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Angela M Koehler | Director | Boston, MA |
| David M Tanen | Director | New York, NY |
| Christopher M Wilfong | Director | Boston, MA |
| Christopher M Wilfong | Executive Officer | Boston, MA |
| David M Tanen | Promoter | New York, NY |
| Christopher M Wilfong | Promoter | Boston, MA |
| David M Tanen | Executive Officer | New York, NY |
Other filings by this issuer (2)
More